Re: Dysrhythmias with Loperamide Used for Opioid Withdrawal

References

1. 1.↵
   1. Vithalani ND,
   2. Heron C,
   3. Rao RE,
   4. Cardell AF,
   5. Stephens MB

   . Dysrhythmias with loperamide used for opioid withdrawal. J Am Board Fam Med 2017;30:832–4.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Wu PE,
   2. Juurlink DN

   . Clinical review: Loperamide toxicity. Ann Emerg Med 2017;70:245–52.

   OpenUrl
3. 3.↵
   1. Wenzel-Seifert K,
   2. Wittmann M,
   3. Haen E

   . QTc Prolongation by psychotropic drugs and the risk of torsade de pointes. Deutsches Ärzteblatt International 2011;108:687–93.

   OpenUrl
4. 4.↵
   1. Ackerman MJ,
   2. Priori SG,
   3. Willems S,
   4. et al

   . HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011;8:1308–39.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Gunaruwan P,
   2. Howes LG

   . Assessing the arrhythmogenic potential of new drugs: A guide for the pharmaceutical physician. Pharm Med 2015;29:11–6.

   OpenUrl